Pancreatic Cancer Dietary Assessment Study

CompletedOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

July 3, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

May 31, 2021

Conditions
Pancreatic NeoplasmPancreas AdenocarcinomaWell-Differentiated Neuroendocrine CarcinomaMalignant Neoplasm of Pancreas
Interventions
DIAGNOSTIC_TEST

Pancreo-KIT breath test

"Pancreo-Kit (Isomed Pharma, Madrid, Spain) is a breath test devised to measure Pancreatic Enzyme Insufficiency. It is a non-invasive method to obtain information about the digestion of consumed lipids; this in turn is informative about the exocrine enzyme activity of the pancreas (specifically pancreatic lipase). This kit is manufactured to EC directive 98/79/EEC and carries the CE mark.~The test is based on measurement of 13C which is a stable naturally occurring environmental isotope of carbon with a nucleus containing 6 protons and 7 neutrons (note, it is not radioactive)."

Trial Locations (1)

M20 4BX

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
collaborator

Pancreatic Cancer UK

OTHER

lead

The Christie NHS Foundation Trust

OTHER

NCT03616431 - Pancreatic Cancer Dietary Assessment Study | Biotech Hunter | Biotech Hunter